Cellectar Biosciences, Inc. Operating Lease Liability
Cellectar Biosciences, Inc. (CLRB) had Operating Lease Liability of $1.53 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $1.53M.
- 2026-03-31: Operating Lease, Liability $1.53M.
- 2025-12-31: Operating Lease, Liability $410.00K.
- 2025-09-30: Operating Lease, Liability $433.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.53M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $410.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $433.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $454.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $476.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $494.00K 10-K · filed 2025-03-13 |
| 2024-09-30 | $513.00K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $531.00K 10-Q · filed 2024-10-29 |
| 2024-03-31 | $548.00K 10-Q/A · filed 2024-10-29 |
| 2023-12-31 | $553.00K 10-K/A · filed 2024-10-29 |
| 2023-09-30 | $569.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $585.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $600.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $604.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $202.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $236.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $269.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $302.00K 10-K · filed 2022-03-21 |
| 2021-09-30 | $333.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $364.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $393.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $422.00K 10-K · filed 2021-03-02 |
| 2020-09-30 | $450.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $476.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $502.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $528.00K 10-K · filed 2020-03-09 |
| 2019-09-30 | $552.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $576.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $598.00K 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |